|本期目录/Table of Contents|

[1]谢江波 温燕华 衷涛 何涛 李良 祝文涛 李顺辉.药物涂层球囊在糖尿病患者冠状动脉小血管病变中的疗效分析[J].国际心血管病杂志,2019,05:297-300.
　XIE Jiangbo,WEN Yanhua,ZHONG Tao,et al.Efficacy of drug-coated balloon for the treatment of small vessel coronary artery disease in diabetic patients[J].International Journal of Cardiovascular Disease,2019,05:297-300.
点击复制

药物涂层球囊在糖尿病患者冠状动脉小血管病变中的疗效分析(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2019年05期
页码:
297-300
栏目:
临床研究
出版日期:
2019-10-23

文章信息/Info

Title:
Efficacy of drug-coated balloon for the treatment of small vessel coronary artery disease in diabetic patients
作者:
谢江波 温燕华 衷涛 何涛 李良 祝文涛 李顺辉
330000 南昌大学第三附属医院心内一科
Author(s):
XIE Jiangbo;  WEN Yanhua;  ZHONG Tao;  HE Tao;  LI Liang;  ZHU Wentao;  LI Shunhui.
Department of Cardiology, the Third Affiliated Hospital of Nanchang University, Jiangxi 330008, China
关键词:
药物涂层球囊; 冠状动脉粥样硬化性心脏病; 小血管病变; 糖尿病
Keywords:
Drug-coated balloon;  Coronary heart disease;  Small vessel coronary artery disease;  Diabetes
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2019.05.011
文献标识码:
-
摘要:
目的：观察药物涂层球囊（DCB）在糖尿病（DM）患者冠状动脉小血管病变应用中的有效性及近期疗效。 方法：入选DM冠状动脉小血管病变患者39例，均单独应用DCB治疗，记录治疗前后最小管腔直径（MLD）、手术即刻成功率及主要不良心血管事件（MACE）发生率。6个月后复查冠状动脉造影，观察靶血管MLD，计算晚期管腔丢失（LLL）。 结果：39例患者共46处病变接受DCB治疗，DCB扩张后，1处病变管壁急性弹性回缩，2处病变出现C型夹层，给予补救性置入药物洗脱支架（DES），手术即刻成功率93.48%，术后即
Abstract:
Objective:To investigate the short-term efficacy of using drug-coated balloon (DCB) to treat small vessel coronary artery disease in patients with diabetes. Methods:A total of 39 diabetic patients with small vessel coronary artery disease were included an

参考文献/References

［1］ Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: the task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)［J］. Eur Heart J, 2006, 28(1):88-136.
［2］ Cortese B, Micheli A, Picchi A, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study［J］. Heart, 2010, 96(16):1291-1296.
［3］ Latib A, Colombo A, Castriota F, et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study［J］. J Am Coll Cardiol, 2012, 60(24):2473-2480.
［4］ Alfonso F, García-Guimaraes M. Optimal coronary interventions in small vessels: is size all that matters?［J］. JACC Cardiovasc Interv, 2016, 9(13):1335-1337.
［5］ 陈韵岱, 王建安, 刘斌, 等. 药物涂层球囊临床应用中国专家共识［J］. 中国介入心脏病学杂志, 2016, 24(2):61-67.
［6］ Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, et al. Long-term results of everolimus-eluting stents versus drug-eluting balloons in patients with bare-metal in-stent restenosis: 3-year follow-up of the RIBS Ⅴ clinical trial［J］. JACC Cardiovasc Interv, 2016, 9(12):1246-1255.
［7］ Unverdorben M, Kleber FX, Heuer H, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD Ⅰ study: are lesions clinically stable from 12 to 36 months?［J］. EuroIntervention, 2013, 9(5):620-628.
［8］ Giannini F, Latib A, Ancona MB, et al. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels［J］. Catheter Cardiovasc Interv, 2017, 90(3):380-386.
［9］ Tanimoto S, Daemen J, Tsuchida K, et al. Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries［J］. Catheter Cardiovasc Interv, 2007, 69(1):94-103.
［10］ Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis［J］. Circulation, 2004, 110(7):810-814.
［11］ Richelsen RB, Overvad TF, Jensen SE. Drug-eluting balloons in the treatment of coronary de novo lesions: a comprehensive review［J］. Cardiol Ther, 2016, 5(2):133-160.
［12］ Mieres J, Fernandez-Pereira C, Risau G, et al. One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the DiabEtic Argentina Registry(DEAR)［J］. Cardiovasc Revasc Med, 2012, 13(5):265-271.
［13］ Waksman R, Serra A, Loh JP, et al. Drug-coated balloons for de novo coronary lesions: results from the Valentines Ⅱ trial［J］. EuroIntervention, 2013, 9(5):613-619.

备注/Memo

备注/Memo:
基金项目：江西省卫生计生委科技计划项目（20187017）
作者单位:330000 南昌大学第三附属医院心内一科
通信作者:李顺辉，Email：lsh661018@163.com
更新日期/Last Update: 2019-10-23